These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7575984)

  • 1. A brief review of the pathophysiology and treatment of cutaneous T-cell lymphoma "mycosis fungoides".
    Gelliarth KA; DeSantis P
    Ostomy Wound Manage; 1995 Oct; 41(9):44-8. PubMed ID: 7575984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The head and neck manifestations of mycosis fungoides.
    Brennan JA
    Laryngoscope; 1995 May; 105(5 Pt 1):478-80. PubMed ID: 7760661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
    Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
    Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
    Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
    Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
    Bouwhuis SA; Davis MD; el-Azhary RA; McEvoy MT; Gibson LE; Knudsen JM; Kist JM; Pittelkow MR
    J Am Acad Dermatol; 2005 Jun; 52(6):991-6. PubMed ID: 15928617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
    Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycosis fungoides.
    Zinzani PL; Ferreri AJ; Cerroni L
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):172-82. PubMed ID: 17950613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cauda equina syndrome complicating cutaneous T-cell lymphoma (mycosis fungoides)].
    Jacquet G; Ranfaing E; Humbert P; Godard J; Steimle R
    Neurochirurgie; 1991; 37(2):123-6. PubMed ID: 1852240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation.
    Kamarashev J; Theler B; Dummer R; Burg G
    Int J Dermatol; 2007 Sep; 46(9):930-5. PubMed ID: 17822495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusterin expression correlates with stage and presence of large cells in mycosis fungoides.
    Chandra P; Plaza JA; Zuo Z; Diwan AH; Koeppen H; Duvic M; Medeiros LJ; Prieto VG
    Am J Clin Pathol; 2009 Apr; 131(4):511-5. PubMed ID: 19289586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological spectrum of mycosis fungoides type cutaneous T-cell lymphoma.
    Shaikh ZI; Rahman SB
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):171-4. PubMed ID: 16542594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycosis fungoides: pathophysiology and emerging therapies.
    Duvic M; Foss FM
    Semin Oncol; 2007 Dec; 34(6 Suppl 5):S21-8. PubMed ID: 18086343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease evolution of patients with mycosis fungoides--a report of 30 cases.
    Berlingeri-Ramos AC; De Jesús G; Sánchez JL; González JR
    P R Health Sci J; 2007 Jun; 26(2):151-4. PubMed ID: 17722429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides and the Sézary syndrome.
    Kim YH; Hoppe RT
    Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
    Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
    J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
    Hagedorn M; Hasche E; Kober B; Sander CA
    Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
    Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
    Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.